Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H30N2O |
Molecular Weight | 349.4978 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN([11CH3])C1(CCCC1)[C@@H](NC(=O)C2=C(C)C=CC=C2C)C3=CC=CC=C3
InChI
InChIKey=BMXRRRIDMAIEKX-SVZFZNDKSA-N
InChI=1S/C23H30N2O/c1-17-11-10-12-18(2)20(17)22(26)24-21(19-13-6-5-7-14-19)23(25(3)4)15-8-9-16-23/h5-7,10-14,21H,8-9,15-16H2,1-4H3,(H,24,26)/t21-/m0/s1/i3-1
Molecular Formula | C23H30N2O |
Molecular Weight | 349.4978 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:45:30 GMT 2023
by
admin
on
Sat Dec 16 11:45:30 GMT 2023
|
Record UNII |
3GD8XN4ZNE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1000022-56-9
Created by
admin on Sat Dec 16 11:45:30 GMT 2023 , Edited by admin on Sat Dec 16 11:45:30 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
GSK-931145-(11C)
Created by
admin on Sat Dec 16 11:45:30 GMT 2023 , Edited by admin on Sat Dec 16 11:45:30 GMT 2023
|
PRIMARY | ((11)C)GSK931145 showed good brain penetration and a heterogeneous distribution in agreement with reported GlyT1 localization. Following pretreatment with GSK565710, uptake of ((11)C)GSK931145 was reduced to homogeneous levels. Although ((11)C)GSK565710 also showed good brain penetration and a heterogeneous distribution, the apparent level of specific binding was reduced compared to ((11)C)GSK931145. In contrast, ((11)C)GSK991022 showed a much lower brain penetration and resultant signal following pretreatment with GSK565710. Based on these findings ((11)C)GSK931145 was identified as the most promising ligand for imaging GlyT1 in the porcine brain, possessing good brain penetration, specific signal, and reversible kinetics. ((11)C)GSK931145 is now being progressed into higher species. | ||
|
44253521
Created by
admin on Sat Dec 16 11:45:30 GMT 2023 , Edited by admin on Sat Dec 16 11:45:30 GMT 2023
|
PRIMARY | |||
|
3GD8XN4ZNE
Created by
admin on Sat Dec 16 11:45:30 GMT 2023 , Edited by admin on Sat Dec 16 11:45:30 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
We report on (11C)GSK931145 as a novel GlyT-1 imaging probe in primate and man. While the distribution and binding potential values were similar across species, both the plasma free fraction (fP: 0.8 vs. 8%) and delivery (K1: 0.025 vs. 0.126 ml cm23 min21) were significantly lower in humans. Test retest reproducibility in humans calculated using a two tissue compartmental model was poor (VAR(VT): 2938%), but was improved using a pseudo reference tissue
model (VAR(BPND): 1623%). GSK1018921 EC50 estimates were 22.5 and 45.7 ng/ml in primates and humans, respectively.
|